85 results
8-K
EX-10.1
CC
Chemours Company
23 Aug 23
Entry into a Material Definitive Agreement
5:23pm
hereto (the “Tranche B-3 Euro Term Lenders”) commit to make the Tranche B-3 Euro Term Loans on the Restatement Effective Date (the commitment of each … Lender’s name on Schedule I hereto, is such Tranche B-3 Euro Term Lender’s “Tranche B-3 Euro Term Commitment”) and (b) the financial institutions set
8-K
EX-99.1
ndom58d
1 Aug 23
Chemours Completes Sale of Glycolic Acid Business to Iron Path Capital-backed PureTech Scientific, LLC for $137 Million
8:04am
8-K
EX-99.1
r9wppdx gy1phfujzey
6 Jun 23
Company Appoints Jonathan Lock as new CFO and Promotes Matt Abbott to Executive Team as SVP, Chief Enterprise Transformation Officer
6:46am
8-K
EX-99.2
q3yu8 pmkws
29 Mar 23
Third Amendment to Amended and Restated Receivables Purchase Agreement
4:07pm
8-K
EX-99.2
vpubbt0m
25 Oct 22
The Chemours Company Reports Third Quarter 2022 Results
4:21pm
8-K
EX-99.1
rkifq4k13y8wyf7qcp99
22 Aug 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-99.2
e2b3 4ctammub0e
28 Jul 22
The Chemours Company Reports Robust Second Quarter 2022 Results
4:23pm
8-K
EX-99.1
hfwxq 8a9
10 Feb 22
The Chemours Company Reports Solid Fourth Quarter and Full Year 2021 Results, Provides Strong Full Year 2022 Outlook
4:45pm
8-K
EX-99.2
x42aht 1l7r
1 Dec 21
Second Amendment to Amended and Restated Receivables Purchase Agreement
4:11pm